Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05910151Unknown

Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan

Role: lead

NCT05375331Unknown

Clinical and Genetic Markers of Bone Metabolism in Children Under One Year

Role: lead

NCT05262088Unknown

Prognostic Value of Generalized Movements in the Diagnosis of Neurological Diseases in Children

Role: lead

NCT05179434Not ApplicableUnknown

A Study of Retrograde Reperfusion of Renal Graft to Reduce Ischemic-reperfusion Injury

Role: lead

All 4 trials loaded